Immunitybio Inc IBRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:24 PM EDT
5.39quote price arrow down-0.18 (-3.23%)
Volume
917,012
52 week range
2.60 - 10.37
Loading...
  • Open5.40
  • Day High5.62
  • Day Low5.13
  • Prev Close5.57
  • 52 Week High10.37
  • 52 Week High Date10/05/21
  • 52 Week Low2.60
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.158B
  • Shares Out400.30M
  • 10 Day Average Volume1.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change-12.42

KEY STATS

  • Open5.40
  • Day High5.62
  • Day Low5.13
  • Prev Close5.57
  • 52 Week High10.37
  • 52 Week High Date10/05/21
  • 52 Week Low2.60
  • 52 Week Low Date05/12/22
  • Market Cap2.158B
  • Shares Out400.30M
  • 10 Day Average Volume1.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change-12.42

RATIOS/PROFITABILITY

  • EPS (TTM)-0.95
  • P/E (TTM)-5.68
  • Fwd P/E (NTM)-6.65
  • EBITDA (TTM)-317.317M
  • ROE (TTM)-3,787.09%
  • Revenue (TTM)510,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-74,814.85%
  • Debt To Equity (MRQ)-146.92%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunitybio Inc

 

Content From Our Affiliates

Profile

MORE
Immunitybio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapies and vaccines that improve the immune system to defeat cancers and infectious diseases. Its immunotherapy and cell therapy platforms include antibody cytokine fusion proteins; synthetic immunomodulators; vaccine technologies, which includes human adenovirus (hAd5) viral vector, and genetically modified off-the-shelf natural killer cells (NK cells), which activate both...
Patrick Soon-Shiong M.D.
Executive Chairman of the Board, Global Chief Scientific and Medical Officer
Richard Adcock
President, Chief Executive Officer, Director
David Sachs
Chief Financial Officer
Address
3530 John Hopkins Ct
San Diego, CA
92121-1121
United States

Top Peers

SYMBOLLASTCHG%CHG
ISEE
IVERIC bio Inc
20.82+1.05+5.28%
RXRX
Recursion Pharmaceuticals Inc
11.63-0.21-1.77%
KRYS
Krystal Biotech Inc
70.08-1.15-1.61%
VTYX
Ventyx Biosciences Inc
36.51+1.05+2.96%
AXSM
Axsome Therapeutics Inc
46.09-0.87-1.85%